NDC 50228-431 – Droxidopa
Droxidopa 300 mg/1 · Capsule · Oral
Product NDC50228-431
Product details
- Brand name
- Droxidopa
- Generic name
- Droxidopa
- Labeler
- ScieGen Pharmaceuticals Inc
- Dosage form
- Capsule
- Route
- Oral
- Marketing category
- ANDA · ANDA214017
- Marketed since
- February 18, 2021
- Listing expires
- December 31, 2026
Active ingredients
- Droxidopa 300 mg/1
Package NDC codes (3)
| Package NDC | Description | Since |
|---|---|---|
| 50228-431-05 | 500 CAPSULE in 1 BOTTLE (50228-431-05) | Feb 18, 2021 |
| 50228-431-30 | 30 CAPSULE in 1 BOTTLE (50228-431-30) | Feb 18, 2021 |
| 50228-431-90 | 90 CAPSULE in 1 BOTTLE (50228-431-90) | Feb 18, 2021 |
Other Droxidopa products
- 67877-705 Droxidopa 200 mg/1 · Capsule · Ascend Laboratories, LLC
- 67877-706 Droxidopa 300 mg/1 · Capsule · Ascend Laboratories, LLC
- 67877-704 Droxidopa 100 mg/1 · Capsule · Ascend Laboratories, LLC
- 59651-377 Droxidopa 300 mg/1 · Capsule · Aurobindo Pharma Limited
- 59651-375 Droxidopa 100 mg/1 · Capsule · Aurobindo Pharma Limited
- 59651-376 Droxidopa 200 mg/1 · Capsule · Aurobindo Pharma Limited
- 69452-256 Droxidopa 100 mg/1 · Capsule · Bionpharma Inc.
- 69452-257 Droxidopa 200 mg/1 · Capsule · Bionpharma Inc.
- 69452-258 Droxidopa 300 mg/1 · Capsule · Bionpharma Inc.
- 31722-010 Droxidopa 300 mg/1 · Capsule · Camber Pharmaceuticals, Inc.
- 31722-014 Droxidopa 100 mg/1 · Capsule · Camber Pharmaceuticals, Inc.
- 31722-015 Droxidopa 200 mg/1 · Capsule · Camber Pharmaceuticals, Inc.